Skip to content

Impact Biomedical Inc.

IBO· NYSECore metricsCIK 1834105

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · +11.74%
Market cap
$41.52M
8.64M shares
Filings
157
$21.00K
Q3 2026−36.0% FY25 yoy
-$645.00K
Q3 2026N/M FY25 yoy
-$648.00K
Q3 2026N/M FY25 yoy
—
—
—
-$0.08
Q3 2026N/M FY25 yoy
$20.00K
Q1 2026−99.8% FY25 yoy
$41.52M
—
1297.3×
4.1×
—
—

FY2025 figures · derived

Price

$4.81+773.64%+$4.26past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$32.00KFY 2025
$50.00K0FY 2022FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$32,000reported
FY 20222022-12-31$50,000reported

Pharmaceutical preparations

Impact Biomedical Inc. is the 252nd largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Impact Biomedical Inc. · CIK 1834105 · Engraved from SEC EDGAR